Beaton Management Company’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.37M | Sell |
6,863
-40
| -0.6% | -$21.7K | 1.5% | 23 |
|
|
2025
Q4 | $4M | Hold |
6,903
| – | – | 1.76% | 17 |
|
|
2025
Q3 | $3.35M | Hold |
6,903
| – | – | 1.52% | 21 |
|
|
2025
Q2 | $2.8M | Sell |
6,903
-20
| -0.3% | -$8.36K | 1.37% | 26 |
|
|
2025
Q1 | $3.44M | Hold |
6,923
| – | – | 1.79% | 18 |
|
|
2024
Q4 | $3.6M | Hold |
6,923
| – | – | 1.82% | 17 |
|
|
2024
Q3 | $4.28M | Sell |
6,923
-200
| -3% | -$118K | 2.17% | 13 |
|
|
2024
Q2 | $3.94M | Buy |
7,123
+13
| +0.2% | +$7.45K | 2.12% | 13 |
|
|
2024
Q1 | $4.13M | Buy |
7,110
+79
| +1% | +$44.3K | 2.25% | 13 |
|
|
2023
Q4 | $3.73M | Hold |
7,031
| – | – | 2.23% | 10 |
|
|
2023
Q3 | $3.56M | Sell |
7,031
-309
| -4% | -$165K | 2.31% | 10 |
|
|
2023
Q2 | $3.83M | Sell |
7,340
-60
| -0.8% | -$32.4K | 2.42% | 8 |
|
|
2023
Q1 | $4.26M | Sell |
7,400
-100
| -1% | -$56.4K | 2.88% | 7 |
|
|
2022
Q4 | $4.13M | Buy |
7,500
+900
| +14% | +$477K | 2.77% | 6 |
|
|
2022
Q3 | $3.35M | Hold |
6,600
| – | – | 2.53% | 8 |
|
|
2022
Q2 | $3.59M | Hold |
6,600
| – | – | 2.54% | 8 |
|
|
2022
Q1 | $3.9M | Hold |
6,600
| – | – | 2.41% | 9 |
|
|
2021
Q4 | $4.4M | Hold |
6,600
| – | – | 2.63% | 6 |
|
|
2021
Q3 | $3.77M | Hold |
6,600
| – | – | 2.49% | 8 |
|
|
2021
Q2 | $3.33M | Hold |
6,600
| – | – | 2.12% | 12 |
|
|
2021
Q1 | $3.01M | Hold |
6,600
| – | – | 2.08% | 13 |
|
|
2020
Q4 | $307K | Hold |
6,600
| – | – | 0.23% | 101 |
|
|
2020
Q3 | $2.91M | Hold |
6,600
| – | – | 2.4% | 9 |
|
|
2020
Q2 | $2.39M | Sell |
6,600
-50
| -0.8% | -$16.8K | 2.13% | 12 |
|
|
2020
Q1 | $1.89M | Sell |
6,650
-100
| -1% | -$31.5K | 1.89% | 14 |
|
|
2019
Q4 | $2.19M | Hold |
6,750
| – | – | 1.72% | 16 |
|
|
2019
Q3 | $1.97M | Sell |
6,750
-100
| -1% | -$28.6K | 1.59% | 19 |
|
|
2019
Q2 | $2.01M | Sell |
6,850
-50
| -0.7% | -$13.8K | 1.67% | 19 |
|
|
2019
Q1 | $1.89M | Sell |
6,900
-100
| -1% | -$24.9K | 1.63% | 20 |
|
|
2018
Q4 | $1.57M | Sell |
7,000
-50
| -0.7% | -$11.7K | 1.54% | 20 |
|
|
2018
Q3 | $1.72M | Hold |
7,050
| – | – | 1.42% | 22 |
|
|
2018
Q2 | $1.46M | Sell |
7,050
-100
| -1% | -$21.2K | 1.31% | 26 |
|
|
2018
Q1 | $1.48M | Hold |
7,150
| – | – | 1.36% | 21 |
|
|
2017
Q4 | $1.36M | Sell |
7,150
-50
| -0.7% | -$9.58K | 1.23% | 25 |
|
|
2017
Q3 | $1.36M | Hold |
7,200
| – | – | 1.28% | 24 |
|
|
2017
Q2 | $1.26M | Buy |
+7,200
| New | +$1.21M | 1.25% | 23 |
|
Other funds holding TMO
VCM
Beaton Management Company's TMO Position: Q1 2026 in Review
Beaton Management Company reduced its Thermo Fisher Scientific (TMO) stake by 0.58% in Q1 2026, selling an estimated $21.7K and leaving 6,863 shares worth $3.37M. The position accounts for 1.5% of the portfolio, ranked #23.
Beaton Management Company first reported a position in TMO in Q2 2017 and has held it in 36 quarters since. The position peaked at $4.4M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Beaton Management Company held 6,863 shares of Thermo Fisher Scientific worth $3.37M as of Q1 2026.
- Beaton Management Company sold 40 Thermo Fisher Scientific shares in Q1 2026, an estimated $21.7K.
- Thermo Fisher Scientific made up 1.5% of Beaton Management Company's portfolio in Q1 2026, its #23 holding.
- Beaton Management Company first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 36 quarters since.
- Beaton Management Company's Thermo Fisher Scientific position peaked at $4.4M in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Beaton Management Company's 13F filing for Q1 2026, filed 12 May 2026.